Literature DB >> 10091158

Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major.

T Arrigo1, G Crisafulli, A Meo, M Sturiale, F Lombardo, M Miceli, D Cucinotta, F De Luca.   

Abstract

Glyco-metabolic status was evaluated in 29 pubertal homozygous thalassaemics aged from 17 to 42 years and in 12 age-matched healthy subjects. Diagnosis of diabetes mellitus was assessed in 4 patients (13.8%), who became diabetic after the age of 18 years. With respect to controls non-diabetic patients exhibited significantly higher fasting plasma glucose levels and more sustained glycemic responses to oral glucose tolerance test, whereas their overall insulin output was significantly lower. Moreover non-diabetic thalassaemic patients showed a clear reduction of both beta-cell function and insulin resistance indices (HOMA model). In conclusion our data show a high prevalence of diabetes but do not support the existence of an insulin resistant status in thalassaemia major, at least in adulthood.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10091158

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  10 in total

Review 1.  Endocrine complications of thalassemia.

Authors:  D Tiosano; Z Hochberg
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

2.  The pancreas in beta-thalassemia major: MR imaging features and correlation with iron stores and glucose disturbances.

Authors:  Olympia Papakonstantinou; Vasilios Ladis; Stavroula Kostaridou; Thomas Maris; Helen Berdousi; Christos Kattamis; Nicholas Gourtsoyiannis
Journal:  Eur Radiol       Date:  2006-12-06       Impact factor: 5.315

Review 3.  Growth and endocrine function in thalassemia major in childhood and adolescence.

Authors:  M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2010-01       Impact factor: 4.256

4.  Three-year prospective evaluation of glucose tolerance, beta-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major.

Authors:  M F Messina; F Lombardo; A Meo; M Miceli; M Wasniewska; M Valenzise; C Ruggeri; T Arrigo; F De Luca
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

5.  Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy.

Authors:  Somchit Jaruratanasirikul; Rarong Chareonmuang; Malai Wongcharnchailert; Vichai Laosombat; Pasuree Sangsupavanich; Kalaya Leetanaporn
Journal:  Eur J Pediatr       Date:  2007-09-25       Impact factor: 3.183

Review 6.  Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis.

Authors:  Li-Na He; Wei Chen; Yi Yang; Ying-Jun Xie; Ze-Yu Xiong; Di-Yu Chen; Dian Lu; Neng-Qing Liu; Ying-Hong Yang; Xiao-Fang Sun
Journal:  Biomed Res Int       Date:  2019-04-18       Impact factor: 3.411

7.  Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot study.

Authors:  Ashraf T Soliman; Mohamed Yasin; Ahmed El-Awwa; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2013-05

8.  Glucose homeostasis in Egyptian children and adolescents with β-Thalassemia major: Relationship to oxidative stress.

Authors:  Kotb Abbass Metwalley; Abdel-Rahman Abdel-Hamed El-Saied
Journal:  Indian J Endocrinol Metab       Date:  2014-05

9.  Effect of long-term transfusion therapy on the glycometabolic status and pancreatic Beta cell function in patients with Beta thalassemia major.

Authors:  Kamalakshi G Bhat; Prakash K Periasamy
Journal:  J Family Med Prim Care       Date:  2014-04

10.  A Cross-Sectional Study of Glycemic Status and Zinc Level in Patients with Beta-Thalassemia Major.

Authors:  Mohammad Ali Mashhadi; Zahra Sepehri; Zahra Heidari; Mahmoud Ali Kaykhaei; Aliyeh Sargazi; Farhad Kohan; Hanieh Heidari
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.